MX362348B - Preparacion de 4-((1r,2s,5r)-6-(benciloxi)-7-oxo-1,6-diazabiciclo[ 3.2.1]octano-2-carboxamido)piperidin-1-carboxilato de ter-butilo. - Google Patents

Preparacion de 4-((1r,2s,5r)-6-(benciloxi)-7-oxo-1,6-diazabiciclo[ 3.2.1]octano-2-carboxamido)piperidin-1-carboxilato de ter-butilo.

Info

Publication number
MX362348B
MX362348B MX2015016976A MX2015016976A MX362348B MX 362348 B MX362348 B MX 362348B MX 2015016976 A MX2015016976 A MX 2015016976A MX 2015016976 A MX2015016976 A MX 2015016976A MX 362348 B MX362348 B MX 362348B
Authority
MX
Mexico
Prior art keywords
formula
preparation
carboxamido
benzyloxy
octane
Prior art date
Application number
MX2015016976A
Other languages
English (en)
Other versions
MX2015016976A (es
Inventor
Nobuyoshi Yasuda
P Miller Steven
Limanto John
Li Zhong Yong-
Liu Zhijian
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of MX2015016976A publication Critical patent/MX2015016976A/es
Publication of MX362348B publication Critical patent/MX362348B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Un procedimiento para la preparación de sulfonatos de 6-(piperidin-4-ilcarbamoil)piperidin-3-ilo N-protegidos de la fórmula III: (ver Fórmula) que comprende poner en contacto una lactona de la fórmula II: (ver Fórmula) con una azacicloalquilamina de fórmula II-Am: (ver Fórmula) seguido por el contacto con un halogenuro de sulfonilo de fórmula II-Su: R4-SO2W (II-Su) en presencia de una base de amina terciaria, en donde PG1 y PG2 son grupos protectores de amina; k, p y q son 0, 1, o 2, y W, R2, R3 R4, R5, R6, R7, R8 y R9 son como se define en la presente; modalidades adicionales añaden una serie de pasos del procedimiento que resultan en la síntesis de 7-oxo-1,6-diazabiciclo[3.2.1]octanos, adecuados para usarse como inhibidores de ß-lactamasa.
MX2015016976A 2013-06-10 2014-06-05 Preparacion de 4-((1r,2s,5r)-6-(benciloxi)-7-oxo-1,6-diazabiciclo[ 3.2.1]octano-2-carboxamido)piperidin-1-carboxilato de ter-butilo. MX362348B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361833108P 2013-06-10 2013-06-10
US201361886759P 2013-10-04 2013-10-04
PCT/US2014/040983 WO2014200786A1 (en) 2013-06-10 2014-06-05 Preparation of tert-butyl 4-((1r,2s,5r)-6- (benzyloxy)-7-0x0-1,6-diazabicycl0[3.2.i]octane-2- carboxamido)piperidine-1-carboxylate

Publications (2)

Publication Number Publication Date
MX2015016976A MX2015016976A (es) 2016-04-25
MX362348B true MX362348B (es) 2019-01-11

Family

ID=52022668

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015016976A MX362348B (es) 2013-06-10 2014-06-05 Preparacion de 4-((1r,2s,5r)-6-(benciloxi)-7-oxo-1,6-diazabiciclo[ 3.2.1]octano-2-carboxamido)piperidin-1-carboxilato de ter-butilo.

Country Status (12)

Country Link
US (1) US9604985B2 (es)
EP (1) EP3008069B1 (es)
JP (1) JP6427173B2 (es)
KR (1) KR102265772B1 (es)
CN (1) CN105283458B (es)
AU (1) AU2014278556B2 (es)
BR (1) BR112015030470B1 (es)
CA (1) CA2911544A1 (es)
MX (1) MX362348B (es)
PH (1) PH12015502751A1 (es)
RU (1) RU2689339C2 (es)
WO (1) WO2014200786A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3227306B1 (en) 2014-12-02 2020-07-15 Merck Sharp & Dohme Corp. Process for the preparation of tert-butyl 4-((2s,5r)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)piperidine-1-carboxylate and analogs thereof
US10472345B2 (en) 2016-02-04 2019-11-12 Merck Sharp & Dohme Corp. Methods of preparing hydroxylamine derivatives useful in the preparation of anti-infective agents
US10464937B2 (en) * 2016-09-19 2019-11-05 Merck Sharp & Dohme Corp. Process for preparing beta-lactamase inhibitor hydroxylurea intermediates
US11897844B2 (en) 2018-09-21 2024-02-13 Api Corporation Method for producing amino acid derivatives
EP3959205A4 (en) * 2019-04-26 2023-05-17 Merck Sharp & Dohme LLC METHOD FOR THE PREPARATION OF INTERMEDIATES USEFUL FOR THE MANUFACTURE OF (2S,5R)-7-OXO-N-PIPERIDIN-4-YL-6-(SULFOXY)-1,6-DIAZABICYCLO[3.2.1]OCTANE-2-CARBOXAMIDE
CN111606844A (zh) * 2020-05-29 2020-09-01 江西富祥药业股份有限公司 一种瑞利巴坦中间体的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2090393T3 (es) * 1991-04-11 1996-10-16 Hoffmann La Roche Beta-lactamas.
FR2812635B1 (fr) * 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
AU2004247559B2 (en) * 2003-06-12 2009-08-27 Astellas Pharma Inc. Benzamide derivative or salt thereof
US20100009957A1 (en) 2006-09-27 2010-01-14 Blizzard Timothy A Novel inhibitors of beta-lactamase
MY162532A (en) * 2008-01-18 2017-06-15 Merck Sharp & Dohme Beta-lactamase inhibitors
US20120053350A1 (en) * 2009-04-30 2012-03-01 Ian Mangion Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids

Also Published As

Publication number Publication date
US20160122350A1 (en) 2016-05-05
AU2014278556B2 (en) 2018-07-19
RU2015155607A3 (es) 2018-03-14
BR112015030470A2 (pt) 2017-07-25
EP3008069A1 (en) 2016-04-20
EP3008069B1 (en) 2018-01-03
US9604985B2 (en) 2017-03-28
JP2016520648A (ja) 2016-07-14
CN105283458B (zh) 2018-05-22
BR112015030470B1 (pt) 2022-08-16
PH12015502751A1 (en) 2016-03-14
MX2015016976A (es) 2016-04-25
JP6427173B2 (ja) 2018-11-21
RU2689339C2 (ru) 2019-05-27
RU2015155607A (ru) 2017-07-24
KR20160018524A (ko) 2016-02-17
CN105283458A (zh) 2016-01-27
WO2014200786A1 (en) 2014-12-18
KR102265772B1 (ko) 2021-06-15
CA2911544A1 (en) 2014-12-18
AU2014278556A1 (en) 2015-11-12
EP3008069A4 (en) 2016-11-30

Similar Documents

Publication Publication Date Title
PH12015502751A1 (en) Preparation of tert-butyl 4-((1r,2s,5r)-6- (benzyloxy)-7-0x0-1,6-diazabicycl0[3.2.i]octane-2- carboxamido)piperidine-1-carboxylate
PH12016501822A1 (en) Cyclopropaneamine compound
EA201890450A1 (ru) Циклические динуклеотидные соединения в качестве агонистов sting
ECSP15012804A (es) Alcoxipirazoles como activadores de guanilato ciclasa soluble
CU24265B1 (es) Compuestos derivados de benzamida para inhibir la actividad de abl1, abl2 y bcr-abl1, útiles en el tratamiento del cáncer
PE20160546A1 (es) Compuestos derivados de piridilo biciclicos fusionados a anillo como inhibidores de fgfr4
CY1117773T1 (el) Νεες χειρικες ν-ακυλ-5,6,7,8-υποκατεστημενες)-τετραϋδρο-[1,2,4]τριαζολο[4,3-a]πυραζινες ως επιλεκτικοι ανταγωνιστες του υποδοχεα νκ-3, φαρμακευτικη συνθεση και μεθοδοι για τη χρηση σε διαταραχες μεσολαβουμενες απο τον υποδοχεα νκ-3
EA201891917A1 (ru) Бициклические гетероциклические производные в качестве ингибиторов irak4
UA108926C2 (ru) LibreOffice? [2,3-D] +" +" !+
CO7170131A2 (es) Compuestos de heterociclilo
PH12017500111A1 (en) Heterocyclic carboxylic acids as activators of soluble guanylate cyclase
EA201491149A1 (ru) Пиразолопиридиновые производные, способы их получения и их терапевтическое применение
MD20150048A2 (ro) Derivaţi ai pirolotriazinonei în calitate de inhibitori ai PI3K
MY186599A (en) Substituted pyridopyrazines as novel syk inhibitors
PE20141352A1 (es) Fenil-3-aza-biciclo[3,1,0]hex-3-il-metanonas y su uso como medicamento
EA201001481A1 (ru) Производные третичного амина в качестве ингибиторов фосфодиэстеразы-4
EA201200602A1 (ru) Индазолы и пиразолопиридины в качестве антагонистов рецептора ccr1
EA201391056A1 (ru) Гетероарильные соединения в качестве лигандов 5-htрецептора
MX2015014025A (es) Derivados de n-(2,3-dihidro-1h-pirrolo[2,3,b]piridin-5-il)-4-quina zolinamina y n-(2,3-dihidro-1h-indol-5-il)-4-quinazolinamina novedosos como inhibidores de perk.
ECSP13012548A (es) Inhibidores de oxadiazol de la producción de leucotrienos.
EA201590372A1 (ru) Бициклические гетероарилциклоалкилдиаминовые производные в качестве ингибиторов тирозинкиназ селезенки (syk)
PE20170668A1 (es) Compuesto de pirazolotiazol y medicamento que comprende el mismo
NZ720805A (en) Processes for the preparation of pyrimidinylcyclopentane compounds
GB2556535A (en) A method for preparation of ibrutinib precursor
MY168411A (en) Method for preparing compound by novel michael addition reaction using water or various acids as additive

Legal Events

Date Code Title Description
FG Grant or registration